Literature DB >> 31428857

Elevated expression of cellular SYNE1, MMP10, and GTPase1 and their regulatory role in hepatocellular carcinoma progression.

Laila H Faraj Shaglouf1, Maryam Ranjpour1, Saima Wajid1, Swatantra Kumar Jain2.   

Abstract

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy resulting in high mortality. HCC progression is associated with abnormal signal transduction that changes cell signaling pathways and ultimately leads to dysregulation of cell functions and uncontrolled cell proliferation. Present study was undertaken with the objective to identify differentially expressed proteins and quantify their transcript expression in the liver of HCC-bearing rats vis-à-vis controls and to decipher the network involving interaction of genes coding for the characterized proteins to an insight into mechanism of HCC tumorigenesis. 2D-Electrophoresis and MALDI-TOF-MS/MS were used to characterize differentially expressed proteins in DEN (diethylnitrosamine)-induced HCC tissue using the protocol reported by us earlier. Real-time PCR was performed to quantify the expression of transcripts for the identified proteins. GENEMANIA, an interacting network of genes coding for selected proteins, was deciphered that provided the functional role of these proteins in HCC progression. Upregulation of proteins SYNE1, MMP10, and MTG1 was observed. The mRNA quantification revealed elevated expression of their transcripts at HCC initiation, progression, and tumor stages. Network analysis showed the involvement of the genes coding for these proteins in dysregulation of signaling pathways during HCC development. The elevated expression of SYNE1, MMP10, and MTG1 suggests the role of these proteins as potential players in HCC progression and tumorigenesis.

Entities:  

Keywords:  Hepatocellular carcinoma; MMP10; MTG1 and gene interaction network; SYNE1

Mesh:

Substances:

Year:  2019        PMID: 31428857     DOI: 10.1007/s00709-019-01423-w

Source DB:  PubMed          Journal:  Protoplasma        ISSN: 0033-183X            Impact factor:   3.356


  52 in total

1.  Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.

Authors:  Arnaud Monvoisin; Christèle Bisson; Karim Si-Tayeb; Charles Balabaud; Alexis Desmoulière; Jean Rosenbaum
Journal:  Int J Cancer       Date:  2002-01-10       Impact factor: 7.396

2.  Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.

Authors:  Moritz Jesinghaus; Thomas Wolf; Nicole Pfarr; Alexander Muckenhuber; Aysel Ahadova; Arne Warth; Benjamin Goeppert; Christine Sers; Matthias Kloor; Volker Endris; Albrecht Stenzinger; Wilko Weichert
Journal:  Am J Surg Pathol       Date:  2015-08       Impact factor: 6.394

3.  STAT3 promotes the proliferation and migration of hepatocellular carcinoma cells by regulating AKT2.

Authors:  Yi Xie; Jianmin Li; Chao Zhang
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

4.  DEN+2-AAF-induced multistep hepatotumorigenesis in Wistar rats: supportive evidence and insights.

Authors:  Shabnam Malik; Shilpa Bhatnagar; Naveen Chaudhary; Deepshikha Pande Katare; S K Jain
Journal:  Protoplasma       Date:  2012-03-29       Impact factor: 3.356

5.  Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.

Authors:  Gi-Ae Kim; Han Chu Lee; Min-Ju Kim; Yeonjung Ha; Eui Ju Park; Jihyun An; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim
Journal:  J Hepatol       Date:  2014-11-28       Impact factor: 25.083

6.  Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.

Authors:  M F Yuen; P C Wu; V C Lai; J Y Lau; C L Lai
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

Review 7.  Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends.

Authors:  Matthias S Matter; Thomas Decaens; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2013-12-03       Impact factor: 25.083

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma.

Authors:  Myoung Sook Han; Tamera Barrett; Michael A Brehm; Roger J Davis
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

10.  MMP-10/stromelysin-2 promotes invasion of head and neck cancer.

Authors:  Elsayed Mohamed Deraz; Yasusei Kudo; Maki Yoshida; Mariko Obayashi; Takaaki Tsunematsu; Hirotaka Tani; Samadarani B S M Siriwardena; Mohammad Reza Keikhaee; Mohammad Reza Kiekhaee; Guangying Qi; Shinji Iizuka; Ikuko Ogawa; Giuseppina Campisi; Lorenzo Lo Muzio; Yoshimitsu Abiko; Akira Kikuchi; Takashi Takata
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

View more
  5 in total

1.  Elevated expression of ISY1, APOA-1, SYNE1, MTG1, and MMP10 at HCC initiation: HCC specific protein network involving interactions of key regulators of lipid metabolism, EGFR signaling, MAPK, and splicing pathways.

Authors:  Laila H Faraj Shaglouf; Maryam Ranjpour; Saima Wajid; Rakesh Tandon; Karisangal Ramaswamy Vasudevan; Swatantra Kumar Jain
Journal:  Protoplasma       Date:  2022-08-12       Impact factor: 3.186

2.  The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma.

Authors:  Yubo Ding; Jingwei Yao; Meiling Wen; Xiong Liu; Jialu Huang; Minghui Zhang; Yu Zhang; Yufan Lv; Zhuoyi Xie; JianHong Zuo
Journal:  PeerJ       Date:  2022-05-17       Impact factor: 3.061

3.  SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients.

Authors:  Pengju Li; Jeifei Xiao; Bangfen Zhou; Jinhuan Wei; Junhang Luo; Wei Chen
Journal:  Aging (Albany NY)       Date:  2020-10-08       Impact factor: 5.682

4.  Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain-containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma.

Authors:  Maryam Ranjpour; Saima Wajid; Swatantra Kumar Jain
Journal:  Protoplasma       Date:  2021-03-08       Impact factor: 3.356

5.  SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer.

Authors:  Yu-De Chu; Kwong-Ming Kee; Wey-Ran Lin; Ming-Wei Lai; Sheng-Nan Lu; Wen-Hung Chung; See-Tong Pang; Chau-Ting Yeh
Journal:  Biomedicines       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.